Montreux, Switzerland

Jean-Pierre Lebet

This inventor holds 18 USPTO granted patents, primarily in Cigarette Filter Technology. Top assignees: Baumgartner Papiers S.a., Symtonic, S.a., Baumgartner Papier S.a.. Active years: 1977-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Lebet. Retrieved from https://idiyas.com/inventor/jean-pierre-lebet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.8

ph-index = 10

Forward Citations = 447(Granted Patents)


Location History:

  • Montreaux, CH (1980 - 1995)
  • Montreux, CH (1977 - 1997)

Company Filing History:


Years Active: 1977-1997

Loading Chart...
Areas of Expertise:
Cigarette Filters
Low Energy Emission
Neurovegetative Disorders
Transverse Flow
Aromatizing Tobacco
Filamentary Material
Production Methods
Control Devices
Filter Units
Rod-Shape Elements
Therapy Applications
Apparatus Design
18 patents (USPTO):Explore Patents

Title: Jean-Pierre Lebet: Innovator in Low Energy Emission Therapy

Introduction:

Meet Jean-Pierre Lebet, a prolific inventor and contributor to the field of low energy emission therapy. Hailing from Montreux, Switzerland, Lebet has made significant contributions to the medical industry through his groundbreaking patents. With his expertise in this specialized field, Lebet has created new possibilities for patients suffering from insomnia and general anxiety disorders. Let's explore his latest patents, career highlights, collaborations, and the impact of his innovations.

Latest Patents:

Lebet's latest patents focus on a program storage device and method for applying low energy emission therapy. In these inventions, he presents a therapeutic system consisting of an emitter of low energy electromagnetic emissions and a probe to apply these emissions to patients. The emitter emits high-frequency electromagnetic emissions, modulated by multiple modulation signals. An impedance transformer is also incorporated to match the patient's impedance with the output of the emitter. These patents specifically outline treatment options for insomnia and general anxiety disorders, including panic attacks.

Career Highlights:

Jean-Pierre Lebet's career has been defined by his commitment to expanding the possibilities of low energy emission therapy. With a total of 18 patents to his name, Lebet has demonstrated his expertise and passion for improving patient well-being. His inventions have the potential to provide non-invasive and effective therapies for individuals suffering from insomnia and general anxiety disorders.

Collaborations:

Throughout his career, Jean-Pierre Lebet has collaborated with various companies in the pursuit of advancing low energy emission therapy. He has notably worked with Baumgartner Papiers S.A. and Symtonic S.A. These collaborations have allowed Lebet to combine his technical knowledge with the resources and expertise of these companies, resulting in the development of innovative and practical solutions.

Colleagues such as Serge Boegli and Rea-Woun Chang have played an instrumental role in supporting Lebet's research and development efforts. Together, they have contributed to the progress of low energy emission therapy, ensuring that their inventions adhere to the highest standards of efficacy and safety.

Conclusion:

Jean-Pierre Lebet's contribution to the field of low energy emission therapy stands as a testament to his passion for healthcare innovation. His latest patents exhibit his dedication to finding non-invasive treatment options for insomnia and general anxiety disorders. Through collaborations with esteemed companies and colleagues, Lebet has been able to bring his ideas to life and address the pressing needs of patients worldwide. With his expertise and commitment to excellence, Jean-Pierre Lebet continues to make significant strides in improving the lives of individuals suffering from these conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…